- An Unusual Case of Spontaneous Remission of Hodgkin's Disease after a Single Cycle of COPP-ABV Chemotherapy Followed by Infectious Complications
-
Bang S, Cheong JW, Yang WI, Hahn JS
- KMID: 1734079
- Yonsei Med J.
- 2005 Jun;46(3):425-430.
- doi: 10.3349/ymj.2005.46.3.425
Advanced Hodgkin's disease is usually treated with six or more cycles of combination chemotherapy. Spontaneous regression of the cancer is very rarely reported in patients with Hodgkin's disease. We present... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Cyclophosphamide, Epirubicin, Vincristine, Prednisone, and Etoposide (CEOP-E) for Aggressive Non-Hodgkin 's Lymphoma
-
Kim JG, Sohn SK, Kim DH, Baek JH, Park TI, Lee KB
- KMID: 1778563
- J Korean Med Sci.
- 2004 Dec;19(6):820-825.
- doi: 10.3346/jkms.2004.19.6.820
The main objectives of the current study were to evaluate the efficacy and safety of a CEOP-E regimen for patients with aggressive non-Hodgkin's lymphoma (NHL). Fifty-one consecutive patients with newly... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary non-Hodgkin's Lymphoma of the Bladder with Bone Marrow Involvement
-
Oh KC, Zang DY
- KMID: 759633
- Korean J Intern Med.
- 2003 Mar;18(1):40-44.
Involvement of the lower urinary tract by advanced non-Hodgkin's lymphoma (NHL) has been reported in up to 13% of cases, but primary NHL of the urinary bladder is very rare.... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Course of Patients with IgA Nephropathy between Combined Treatment of Immunosuppressive Agents and ACE Inhibitor and ACE Inhibitor alone
-
Hwang YC, Lee TW, Kim MJ, Yang MH, Ihm CG
- KMID: 938275
- Korean J Intern Med.
- 2001 Jun;16(2):105-109.
BACKGROUND: It has not been clear whether immunosuppressive therapy favorably influences renal function and proteinuria in IgA nephropathy (IgAN). Angiotensin converting enzyme inhibitor (ACEi) has an anti-proteinuric effect in IgAN.... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes of a Modified CALGB 19802 Regimen in Adult Acute Lymphoblastic Leukemia
-
Han AR, Kim K, Jang JH, Kim WS, Ahn JS, Jung CW, Lee MH, Kang WK
- KMID: 1713461
- J Korean Med Sci.
- 2008 Apr;23(2):278-283.
- doi: 10.3346/jkms.2008.23.2.278
We analyzed the efficacy and toxicity of a modified Cancer and Leukemia Group B (CALGB) 19802 regimen in adult acute lymphoblastic leukemia (ALL). From February 2002 to August 2005, 25... -
- CITED
-
- Close
- SHARE
-
- Close
- High-dose Versus Low-dose Cyclophosphamide in Combination with G-CSF for Peripheral Blood Progenitor Cell Mobilization
-
Ahn JS, Park S, Im SA, Yoon SS, Lee JS, Kim BK, Bang SM, Cho EK, Lee JH, Jung CW, Kim HC, Seong CM, Lee MH, Kim CS, Lee KS, Lee JA, Ahn MJ
- KMID: 1782234
- Korean J Intern Med.
- 2005 Sep;20(3):224-231.
- doi: 10.3904/kjim.2005.20.3.224
BACKGROUND: To compare the mobilizing effects and toxicities of two different doses of cyclophosphamide (CY) plus lenograstim (glycosylated G-CSF), we performed a prospective randomized study by enrolling patients suffering with... -
- CITED
-
- Close
- SHARE
-
- Close
- Suppression of hepatic tumor growth and metastasis by metronomic therapy in a rat model of hepatocellular carcinoma
-
Jang JW, Park ST, Kwon JH, You CR, Choi JY, Jung CK, Bae SH, Yoon SK
- KMID: 1009970
- Exp Mol Med.
- 2011 May;43(5):305-312.
- doi: 10.3858/emm.2011.43.5.033
Although continuous low-dose (metronomic [MET]) therapy exerts anti-cancer efficacy in various cancer models, the effect of long-term MET therapy for hepatocellular carcinoma (HCC) remains unknown. This study assessed the long-term... -
- CITED
-
- Close
- SHARE
-
- Close
